A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
| Image |  |
|---|---|
| Description | scientific article published on 01 April 2020 |
| Author/s |
author: Frederick R. Appelbaum Mark R Litzow |
| Publication date | April 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |